The Medicines Company to Announce Second Quarter and First Half 2013 Financial Results on Wednesday, July 24, 2013
Conference Call to Be Held at 8:30 a.m. Eastern Time
(firmenpresse) - PARSIPPANY, NJ -- (Marketwired) -- 07/11/13 -- The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, July 24 at 8:30 a.m. Eastern Time to discuss second quarter and first half 2013 financial results, operational developments, and outlook for 2013.
The conference call will be available via phone and webcast. The dial in information is listed below:
Domestic Dial In: 866 515 2913
International Dial In: +617 399 5127
Passcode for both dial in numbers: 42165066
Replay is available from 10:30 a.m. Eastern Time following the conference call through August 8, 2013. To hear a replay of the call dial 888 286.8010 (domestic) and 617 801 6888 (international). Passcode for both dial in numbers is 40760900.
This call is being webcast and can be accessed via The Medicines Company website at .
The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is .
Contact:
Michael Mitchell
The Medicines Company
973-290-6000
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 11.07.2013 - 14:05 Uhr
Sprache: Deutsch
News-ID 1244762
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PARSIPPANY, NJ
Phone:
Kategorie:
Healthcare
Anmerkungen:
Diese Pressemitteilung wurde bisher 145 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Medicines Company to Announce Second Quarter and First Half 2013 Financial Results on Wednesday, July 24, 2013
"
steht unter der journalistisch-redaktionellen Verantwortung von
The Medicines Company (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
